GD (General Devices), located in Ridgefield, New Jersey, entered the medical devices market in 1979 with ECG diagnostic information transmitters and ECG testing units. Encompassing a passion to improve the health and well-being of the public at large through EMS-hospital communications, GD innovated the industry in 1990, and remains its core market. GD innovations combine speed, simplicity, and reliability to improve preparedness and provide smarter patient care. Having the most hospital customers, over 500, and leveraging exceptional in-house sales, support, engineering and manufacturing teams,

GD is poised to continue building on its growth and expand its dominance in the EMS-hospital communications and mobile telemedicine markets. It accomplishes this through Responsive Innovation – a core value.  “Responsive Innovation” defines GD - who we are and what we do. GD believes in challenging the status quo. We do this by responding to changing needs with innovative solutions that are well-designed and simple to use for the benefit of the public, communities, responders and care providers alike.  Our innovative spirit continues to push the envelope with nextgen communications and mobile solutions with an eye to the future.


Product innovations include the GD CAREpoint™ Workstation used by hospital emergency departments to manage all EMS-hospital communications on a single interoperable, easy-to-use device; and GD e-Bridge™ Mobile Telemedicine apps, which enable the sharing of real-time, HIPAA-secure voice, texts, photos, videos, and streaming video from smartphones, tablets, and PCs between EMS, mobile integrated health-community paramedicine, hospitals and public safety entities.

With a core focus on ease of use, flexibility, and implementation, GD offers the most comprehensive solutions available. GD empowers hospitals, EMS, public safety responders, and community healthcare providers to reduce risk and cost while improving workflow and patient outcomes through documenting, recording, and analyzing patient data.

GD's Partial Timeline

mobile telemedicine timeline


To improve the health and well being of the public at large, by providing Responsive Innovation that connects first responders and healthcare providers.


• Embrace Responsive Innovation
• Be part of a Fun, Diverse team
• Be All-In


 GD Solutions

Public Safety communications

In combination, our highly secure and FirstNet-ready GD CAREpoint and GD e-Bridge solutions provide a total, integrated and intelligent hospital-EMS notification, communication and documentation system unlike anything else on the market today. These solutions can integrate with your existing technologies, and they offer mobile telemedicine, call/radio recording, remote call answering, time-stamping, unified 12-lead management, video streaming, live online medical direction, instant recall and replay, one-button team notification, ambulance geo-mapping and so much more. Together, these comprehensive products dramatically enhance patient outcomes and medical team efficiency while reducing medical error and liability. No other FDA-listed offerings available today provides this level of pre-hospital/hospital information sharing, audio/video communication, documentation, notification, case management or workflow automation capability to fully empower and enrich the capabilities of hospitals and EMS.

All design, manufacturing, sales, and support are managed from our New Jersey headquarters with our experienced and dedicated team. We are located in Northern New Jersey close to the George Washington Bridge. It is convenient to Interstates 80 & 95 and less than 30 minutes from Newark Airport. If you are visiting the NJ/NY metropolitan area, we invite you to pay us a visit. We enjoy giving the tour and you'll get to meet the people behind the voices.  Also, we welcome any suggestions as to how we can better serve your needs, please feel free to contact a member of Team GD to share your thoughts and ideas to evoke our Responsive Innovation.


Mobile Telemedicine


GD HIPAA Statement

GD (General Devices) is committed to comply with the U.S. Department of Health and Human Services (HHS) Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy, Security, and Electronic Transaction standards. GD has implemented policies, processes and procedures designed to ensure compliance with Federal and State information security laws, regulations, and rules.

As GD (General Devices) devices and systems typically connect to hospital (Covered Entities) IP/data networks and may involve the transmission, exchange, or management of data which may contain electronic Protected Health Information (ePHI); GD’s data management design and practices are compliant to the HIPAA Security Rule (45 CFR 160, and Subparts A and C of 164), and the HITECH Act of 2009 as applicable to our business and offerings.  Integrating Administrative, Physical and Technical Safeguards (required by the Security Rule), our company, products, and messaging and communication platforms are geared with the intent to protect the confidentiality of ePHI.


    • AES encryption while the info is sitting in the app at rest and while being transmitted.
    • A closed network. Messages cannot be moved out of  GD e-Bridge via email,text or uploading to social media.
    • Information is not saved on the mobile devices file manager or photo gallery.
    • The GD e-Bridge administrator can limit who can send messages to whom thus preserving the chain of custody of patient information.
    • Messages can be configured to auto delete as soon as 60 seconds.
    • The app can be password protected requiring a secure login each time it is opened to prevent unauthorized use.

GD FDA Statement

GD (General Devices) is committed to complying with the U.S. Food and Drug Administration (FDA) requirements. GD has implemented policies, processes, and procedures designed to ensure compliance with FDA regulations, and rules. As a medical device developer, GD is registered as a manufacturer and complies with the FDA’s Center for Devices and Radiological Health (CDRH) regulations for medical device manufacturers 21 CFR 820, and current Good Manufacturing Practices (cGMPs) 21 CFR 110. As such, GD’s facilities, processes, and systems are inspected by the FDA regularly. GD FDA Establishment Registration Number: 2244646

Making Connections

I love my GD Solution!


 Save as PDF